Agilent CrossLab
Agilent product profile
Put Agilent CrossLab quality supplies to work across your lab.
Agilent CrossLab is a growing portfolio of supplies critical to instrument performance and productivity, manufactured to perform seamlessly with a variety of analytical instruments in your lab, regardless of make or model, including:
The growing portfolio features easy-to-use packaging for improved productivity and includes:
In choosing Agilent CrossLab supplies, you can pick up the phone, dial a single number, and be confident that you’re ordering the right supplies for your instruments, regardless of manufacturer. And thanks to Agilent’s global delivery infrastructure you can count on getting the parts you need when you need them.
When you choose Agilent CrossLab, you know you’ll get:
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
